| All (n = 3314) | Group 1 (n = 605) | Group 2 (n = 331) | Group 3 (n = 1229) | Group 4 (n = 1149) | p value |
---|---|---|---|---|---|---|
Remdesivir, % | 35.8 | 24 | 16.4 | 46.9 | 35.9 |  < 0.0001a = **/b = **/c = ** |
Antibiotics, % | 23.2 | 20.3 | 12.7 | 30.6 | 20.1 |  < 0.0001a = **/b = ** |
Steroids, % | 50.4 | 38.1 | 24.6 | 64.7 | 49.2 |  < 0.0001a = **/b = **/c = ** |
Tocilizumab, % | 9.8 | 5 | 3.3 | 15.2 | 8.5 |  < 0.0001b = **/c = ** |
Baricitinib, % | 5.2 | 31.4 | 14.3 | 53.6 | 42.9 | 0.0014b = * |
Anti-coagulant drugs, % | 29.3 | 21 | 14 | 41.3 | 25.4 |  < 0.0001a = **/b = **/c = * |